Study of CX-4945 in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE1
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Study to Investigate Adherence of Patients to Clodronate (Bonefos) Treatment
- Status
- COMPLETED
- Phase
- N/A
Subcutaneous Velcade Plus Oral Melphalan and Prednisone or Plus Cycloposphamide and Prednisone or Plus Prednisone
- Status
- COMPLETED
- Phase
- PHASE2
Plerixafor Harvesting And No Chemotherapy for Transplantation of Autologous STem Cells In Cancer (PHANTASTIC)
- Status
- COMPLETED
- Phase
- NA
Effect of AT7519M Alone and AT7519M Plus Bortezomib in Patients With Previously Treated Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Total Skeletal Irradiation in Multiple Myeloma Before Second Autologous Hematopoietic Stem Cell Transplantation
- Status
- TERMINATED
- Phase
- PHASE1
Efficacy and Safety Study of SyB L-0501 for Patients With Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Pomalidomide in Gene Expression Profiling (GEP)-Defined High-risk Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Bendamustine in Combination With Bortezomib and Pegylated Liposomal Doxorubicin for Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Vertebral Augmentation With Kyphoplasty vs Nonsurgical Mgmt for Vertebral Body Compression Fractures
- Status
- WITHDRAWN
- Phase
- NA
The Pathophysiology of Bortezomib Induced Peripheral Neuropathy
- Status
- UNKNOWN
- Phase
- N/A
"WB-DCE-MRI" in Multiple Myeloma as an Independent Prognostic Factor for Disease-free Survival
- Status
- COMPLETED
- Phase
- NA
Bendamustine Plus Bortezomib Plus Dexamethasone in Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Pomalidomide, Cyclophosphamide and Prednisone (PCP) in Patients With Multiple Myeloma (MM) Relapsed and/or Refractory to Lenalidomide
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pegylated Liposomal Doxorubicin, Bortezomib, Dexamethasone and Lenalidomide for Relapsed/Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Effectiveness of Armodafinil to Treat Cancer-Related Fatigue in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Revlimid And Prednisone Followed By Revlimid, Melphalan And Prednisone In Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE2
Study of Decadron, Biaxin, and Pomalidomide in Relapsed/Refractory Myeloma
- Status
- COMPLETED
- Phase
- PHASE2